Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer, a leading healthcare AI company, today announced that the Centers for Medicare & Medicaid Services (CMS) has accepted its application under Story Health Partners for the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, positioning the company for participation at the program's July 2026 launch. Innovaccer has been accepted across both Early Cardio-Kidney-Metabolic (eCKM) and Cardio-Kidney-Metabolic (CKM) tracks, spanning h...

ST. LOUIS--(BUSINESS WIRE)--As Save A Lot continues to expand its culturally relevant private label offerings, the largest independently owned and operated value-focused grocery store chain in the U.S. is re-launching and expanding its private label Hispanic brand under a new name, La Tierra de Sabores. The refreshed brand features vibrant colors and patterns designed to reflect a more authentic, modern look while maintaining the quality and value Save A Lot shoppers expect. The update marks a...

CHICAGO--(BUSINESS WIRE)--IFT has released a new white paper on food science and technology solutions that help mitigate and adapt to climate change....

NECKARSULM, Alemania--(BUSINESS WIRE)--1GLOBAL, pionero en soluciones de telecomunicaciones globales, y las empresas del Grupo Schwarz, uno de los grupos de tiendas minoristas más grandes del mundo, celebran una alianza estratégica integral. A tal fin, las compañías que forman parte del Grupo Schwarz adquieren una participación del 9,9 % en 1GLOBAL. La empresa actuará como el socio tecnológico exclusivo de la conectividad móvil en los próximos cinco años. En este contexto, 1GLOBAL y Lidl, uno d...

HOUSTON--(BUSINESS WIRE)--ManhattanLife has launched a new product, Home Health Care Enhanced, designed to provide meaningful financial support for extended care delivered in the home. Building on the foundation of Home Health Care Select, the enhanced offering introduces expanded benefits, greater flexibility and broader eligibility to better meet the evolving needs of today’s policyholders and producers. Home Health Care Enhanced is designed to complement other health coverage by helping offs...

PITTSBURGH--(BUSINESS WIRE)--NEP Group, the leading media services provider for live sports and entertainment worldwide, today announced it will highlight its newly launched NEP Platform at the 2026 NAB Show in Las Vegas. The innovative software orchestration system is designed to transform how the industry manages media infrastructure and hybrid workflows, giving broadcasters, rightsholders, leagues, and content creators greater control, flexibility and scalability than ever before. NEP Platfo...

NECKARSULM, Duitsland--(BUSINESS WIRE)--1GLOBAL, een pionier in wereldwijde telecommunicatieoplossingen, en de bedrijven van de Schwarz Group, een van 's werelds grootste retailgroepen, gaan een uitgebreide strategische samenwerking aan. De bedrijven van de Schwarz Group verwerven hiertoe een belang van 9,9 procent in 1GLOBAL. Het bedrijf zal de komende vijf jaar de exclusieve technologiepartner voor mobiele connectiviteit zijn. Deze bekendmaking is officieel geldend in de originele brontaal. V...

REDWOOD CITY, Californie--(BUSINESS WIRE)--  Corcept présente les données complètes de l'essai pivot ROSELLA dans le cadre d'une présentation de dernière minute au congrès de la SGO, avec une publication simultanée dans The Lancet : Lifyorli™ (rélacorilant) plus nab-paclitaxel améliore la survie globale chez les patientes atteintes d'un cancer de l'ovaire résistant au platine Corcept Therapeutics Incorporated (NASDAQ : CORT), une société en phase commerciale engagée dans la découverte et le dév...

REDWOOD CITY, Kalifornien--(BUSINESS WIRE)--  Corcept präsentiert vollständige Daten aus der zulassungsrelevanten ROSELLA-Studie im Rahmen einer Late-Breaker-Präsentation auf der SGO-Konferenz, begleitet von einer gleichzeitigen Veröffentlichung in The Lancet: Lifyorli™ (Relacorilant) Plus Nab-Paclitaxel Improves Overall Survival in Patients with Platinum-Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), ein Unternehmen im kommerziellen Stadium, das sich mit der Erforsc...

REDWOOD CITY, California--(BUSINESS WIRE)--  Corcept presenta en el Congreso de la SGO los resultados completos del ensayo clínico ROSELLA, publicados simultáneamente en The Lancet: Lifyorli™ (relacorilant) en combinación con nab-paclitaxel prolonga la supervivencia de pacientes con cáncer de ovario resistente al platino Corcept Therapeutics Incorporated (NASDAQ: CORT), una empresa biofarmacéutica centrada en la investigación y el desarrollo de tratamientos para enfermedades endocrinológicas, o...